Nuclear Regulatory Commission February 4, 2016 – Federal Register Recent Federal Regulation Documents

Mallinckrodt, LLC.
Document Number: 2016-02131
Type: Notice
Date: 2016-02-04
Agency: Nuclear Regulatory Commission, Agencies and Commissions
The U.S. Nuclear Regulatory Commission (NRC) is considering amending the NRC's Source Materials License No. STB-401 to allow the option to perform direct dose assessment of residual radioactivity in addition to using derived concentration guideline levels (DCGLs) to demonstrate compliance with the license termination criteria at the Mallinckrodt site in St. Louis, Missouri. The NRC staff is issuing an environmental assessment (EA) and finding of no significant impact (FONSI) associated with the proposed action.
LR-ISG-2015-01, Changes to Buried and Underground Piping and Tank Recommendations
Document Number: 2016-02122
Type: Notice
Date: 2016-02-04
Agency: Nuclear Regulatory Commission, Agencies and Commissions
The U.S. Nuclear Regulatory Commission (NRC) is issuing the final License Renewal Interim Staff Guidance (LR-ISG), LR-ISG-2015-01, ``Changes to Buried and Underground Piping and Tank Recommendations.'' This LR-ISG will replace NRC staff-recommended aging management program (AMP) XI.M41, ``Buried and Underground Piping and Tanks,'' and its associated Updated Final Safety Evaluation Report (UFSAR) Summary Description in LR-ISG-2011-03, ``Changes to the Generic Aging Lessons Learned (GALL) Report Revision 2 AMP XI.M41, `Buried and Underground Piping and Tanks'.'' These changes address new recommendations related to buried and underground piping and tanks within the scope of the NRC's regulations for the renewal of operating licenses for nuclear power plants.
Advisory Committee on the Medical Uses of Isotopes: Meeting Notice
Document Number: 2016-02121
Type: Notice
Date: 2016-02-04
Agency: Nuclear Regulatory Commission, Agencies and Commissions
The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on March 17-18, 2016. A sample of agenda items to be discussed during the public session includes: A discussion on the reporting of medical events for various modalities; an update on medical-related events; a discussion on the training and experience requirements for authorized users of alpha and beta emitters; an update on the licensing guidance for yttrium-90 microsphere brachytherapy; and a discussion on the licensing guidance for the Leksell Gamma Knife[supreg] IconTM unit. The agenda is subject to change. The current agenda and any updates will be available at https://www.nrc.gov/reading-rm/doc- collections/acmui/meetings/2016.html or by emailing Ms. Sophie Holiday at the contact information below. Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material. Date and Time for Open Sessions: March 17, 2016, from 9:30 a.m. to 5:00 p.m. and March 18, 2016, from 8:00 a.m. to 11:30 a.m. Data and Time for Closed Sessions: March 17, 2016, from 7:30 a.m. to 9:30 a.m., March 18, 2016, from 7:30 a.m. to 8:00 a.m., and March 18, 2016, from 12:00 p.m. to 1:00 p.m. Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T2-B3, 11545 Rockville Pike, Rockville, Maryland 20852. Public Participation: Any member of the public who wishes to participate in the meeting in person or via phone should contact Ms. Holiday using the information below. The meeting will also be webcast live: video.nrc.gov. Contact Information: Ms. Sophie J. Holiday, email: sophie.holiday@nrc.gov, telephone: (301) 415-7865.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.